Stocks and Investing
Stocks and Investing
Wed, September 20, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gil Blum Reiterated (TSHA) at Strong Buy and Held Target at $5 on, Sep 20th, 2023
Gil Blum of Needham, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $5 on, Sep 20th, 2023.
Gil has made no other calls on TSHA in the last 4 months.
There are 4 other peers that have a rating on TSHA. Out of the 4 peers that are also analyzing TSHA, 0 agree with Gil's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Gil
- Geulah Livshits of "Chardan Capital" Reiterated at Strong Buy and Held Target at $5 on, Tuesday, August 15th, 2023
- Jack Allen of "Baird" Maintained at Buy with Increased Target to $8 on, Tuesday, August 15th, 2023
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $4 on, Tuesday, August 15th, 2023
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $7 on, Monday, August 14th, 2023
Contributing Sources